GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.
Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.
HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th
Shenzhen Hello Tech Energy(301327.SZ): Strong performance hits record high, revenue and net profit both break through.
Johnson & Johnson's financial condition is stable, and Standard and Poor's has removed the downgrade warning.
HK Bull/Bear Outstanding Qty Ratio(52:48) | April 26th
RECOMMEND
Pan Gongsheng: Will implement a moderately loose monetary policy to promote high-quality development of the Chinese economy.
25/04/2025
Canadian Prime Minister Trudeau: No rush to reach agreement with Trump, US side eventually needs to face reality.
25/04/2025
Alphabet (GOOG.US, GOOGL.US) first quarter revenue and profits exceed expectations, driven by AI and cloud computing performance growth.
25/04/2025
